2023 Q4 Form 20-F Financial Statement

#000110465924053379 Filed on April 29, 2024

View on sec.gov

Income Statement

Concept 2023 Q4 2023 2022 Q4
Revenue $1.580B $5.952B $1.082B
YoY Change 46.01% 31.94% -0.77%
Cost Of Revenue $274.8M $1.060B $202.4M
YoY Change 35.8% 40.4% 35.12%
Gross Profit $1.305B $4.892B $879.9M
YoY Change 48.36% 30.24% -6.48%
Gross Profit Margin 82.61% 82.19% 81.3%
Selling, General & Admin $658.2M $2.803B $929.7M
YoY Change -29.2% 3.03% 88.71%
% of Gross Profit 50.43% 57.3% 105.66%
Research & Development $430.2M $1.544B $294.1M
YoY Change 46.28% 30.51% 47.82%
% of Gross Profit 32.95% 31.55% 33.42%
Depreciation & Amortization $256.6M
YoY Change 83.98%
% of Gross Profit 5.25%
Operating Expenses $1.083B $4.311B $1.220B
YoY Change -11.25% 10.95% 77.5%
Operating Profit $222.3M $581.0M -$340.5M
YoY Change -165.27% -548.56% -234.41%
Interest Expense $162.2M $607.8M $115.8M
YoY Change 40.02% 158.54% 1025.83%
% of Operating Profit 72.98% 104.63%
Other Income/Expense, Net -$4.000M $32.97M $7.724M
YoY Change -151.79% 189.08% -817.84%
Pretax Income $380.5M $1.222B -$216.9M
YoY Change -275.39% 944.3% -182.62%
Income Tax $49.22M $122.6M -$32.12M
% Of Pretax Income 12.94% 10.03%
Net Earnings $331.3M $1.099B -$184.8M
YoY Change -279.25% 924.97% -179.29%
Net Earnings / Revenue 20.96% 18.47% -17.07%
Basic Earnings Per Share $1.26
Diluted Earnings Per Share $0.37 $1.22 -$0.21
COMMON SHARES
Basic Shares Outstanding 870.3M
Diluted Shares Outstanding 902.7M

Balance Sheet

Concept 2023 Q4 2023 2022 Q4
SHORT-TERM ASSETS
Cash & Short-Term Investments $12.91B $12.91B $13.21B
YoY Change -2.27% -2.27% 8.04%
Cash & Equivalents $2.473B $2.473B $9.752B
Short-Term Investments $10.44B $10.44B $3.458B
Other Short-Term Assets $442.7M $442.7M $600.8M
YoY Change -26.31% -26.31% 88.8%
Inventory
Prepaid Expenses
Receivables $16.73M $16.73M $9.862M
Other Receivables $3.966M $3.966M $5.714M
Total Short-Term Assets $13.37B $13.37B $13.83B
YoY Change -3.28% -3.28% 6.69%
LONG-TERM ASSETS
Property, Plant & Equipment $2.076B $2.076B $980.7M
YoY Change 111.7% 111.7% 44.6%
Goodwill $801.0K $825.0K
YoY Change -2.91%
Intangibles $1.140M $1.486M
YoY Change -23.28% 224.45%
Long-Term Investments $2.473B $2.473B
YoY Change
Other Assets $4.000M $4.000M $4.000M
YoY Change 0.0% 0.0% 0.0%
Total Long-Term Assets $4.567B $4.567B $1.001B
YoY Change 356.42% 356.42% 46.57%
TOTAL ASSETS
Total Short-Term Assets $13.37B $13.37B $13.83B
Total Long-Term Assets $4.567B $4.567B $1.001B
Total Assets $17.94B $17.94B $14.83B
YoY Change 21.0% 21.0% 8.69%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable $1.408B $1.408B $818.8M
YoY Change 72.0% 72.0% 1517.09%
Accrued Expenses $155.0M $155.0M $151.4M
YoY Change 2.36% 2.36% -69.76%
Deferred Revenue $393.5M $298.8M
YoY Change 31.71% -84.74%
Short-Term Debt $0.00 $0.00 $0.00
YoY Change
Long-Term Debt Due
YoY Change
Total Short-Term Liabilities $4.357B $4.357B $3.031B
YoY Change 43.75% 43.75% 8.87%
LONG-TERM LIABILITIES
Long-Term Debt $0.00 $0.00 $0.00
YoY Change
Other Long-Term Liabilities $125.1M $125.1M $143.6M
YoY Change -12.89% -12.89% -21.69%
Total Long-Term Liabilities $125.1M $125.1M $143.6M
YoY Change -12.89% -12.89% -21.69%
TOTAL LIABILITIES
Total Short-Term Liabilities $4.357B $4.357B $3.031B
Total Long-Term Liabilities $125.1M $125.1M $143.6M
Total Liabilities $4.511B $4.511B $3.186B
YoY Change 41.58% 41.58% 7.36%
SHAREHOLDERS EQUITY
Retained Earnings -$351.0M -$520.0M
YoY Change -32.49% -85.92%
Common Stock $79.00K $564.0K
YoY Change -85.99%
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity $13.43B $13.43B $11.64B
YoY Change
Total Liabilities & Shareholders Equity $17.94B $17.94B $14.83B
YoY Change 21.0% 21.0% 8.69%

Cashflow Statement

Concept 2023 Q4 2023 2022 Q4
OPERATING ACTIVITIES
Net Income $331.3M $1.099B -$184.8M
YoY Change -279.25% 924.97% -179.29%
Depreciation, Depletion And Amortization $256.6M
YoY Change 83.98%
Cash From Operating Activities $926.8M $3.047B $155.5M
YoY Change 495.87% 203.78% -70.92%
INVESTING ACTIVITIES
Capital Expenditures $134.6M
YoY Change 172.91%
Acquisitions $9.000K
YoY Change -99.37%
Other Investing Activities -$489.5M -$9.939B -$725.5M
YoY Change -32.53% 252.86% -256.43%
Cash From Investing Activities -$489.5M -$9.939B -$725.5M
YoY Change -32.53% 252.86% -455.83%
FINANCING ACTIVITIES
Cash Dividend Paid $79.28M
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities -442.2M -417.0M -628.0M
YoY Change -29.59% -37.69% -3031.76%
NET CHANGE
Cash From Operating Activities 926.8M 3.047B 155.5M
Cash From Investing Activities -489.5M -9.939B -725.5M
Cash From Financing Activities -442.2M -417.0M -628.0M
Net Change In Cash -4.810M -7.309B -1.198B
YoY Change -99.6% 194.38% -257.57%
FREE CASH FLOW
Cash From Operating Activities $926.8M $3.047B $155.5M
Capital Expenditures $134.6M
Free Cash Flow $2.912B
YoY Change 205.37%

Facts In Submission

Frame Concept Type Concept / XBRL Key Value Unit
CY2022Q4 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
CY2023Q4 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
CY2023Q4 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
CY2023 dei Entity Central Index Key
EntityCentralIndexKey
0001842827
CY2023 dei Document Fiscal Year Focus
DocumentFiscalYearFocus
2023
CY2023 dei Document Fiscal Period Focus
DocumentFiscalPeriodFocus
FY
CY2023 dei Document Fin Stmt Error Correction Flag
DocumentFinStmtErrorCorrectionFlag
false
CY2023 dei Amendment Flag
AmendmentFlag
false
CY2023 dei Document Type
DocumentType
20-F
CY2023 dei Document Registration Statement
DocumentRegistrationStatement
false
CY2023 dei Document Annual Report
DocumentAnnualReport
true
CY2023 dei Document Period End Date
DocumentPeriodEndDate
2023-12-31
CY2023 dei Current Fiscal Year End Date
CurrentFiscalYearEndDate
--12-31
CY2023 dei Document Transition Report
DocumentTransitionReport
false
CY2023 dei Document Shell Company Report
DocumentShellCompanyReport
false
CY2023 dei Entity File Number
EntityFileNumber
001-40460
CY2023 dei Entity Registrant Name
EntityRegistrantName
KANZHUN LIMITED
CY2023 dei Entity Incorporation State Country Code
EntityIncorporationStateCountryCode
E9
CY2023 dei Entity Address Address Line1
EntityAddressAddressLine1
18/F, GrandyVic Building
CY2023 dei Entity Address Address Line2
EntityAddressAddressLine2
Taiyanggong Middle Road
CY2023 dei Entity Address Address Line3
EntityAddressAddressLine3
Chaoyang District
CY2023 dei Entity Address City Or Town
EntityAddressCityOrTown
Beijing
CY2023 dei Entity Address Postal Zip Code
EntityAddressPostalZipCode
100020
CY2023 dei Entity Address Country
EntityAddressCountry
CN
CY2023 dei Entity Well Known Seasoned Issuer
EntityWellKnownSeasonedIssuer
Yes
CY2023 dei Entity Voluntary Filers
EntityVoluntaryFilers
No
CY2023 dei Entity Current Reporting Status
EntityCurrentReportingStatus
Yes
CY2023 dei Entity Interactive Data Current
EntityInteractiveDataCurrent
Yes
CY2023 dei Entity Filer Category
EntityFilerCategory
Large Accelerated Filer
CY2023 dei Entity Emerging Growth Company
EntityEmergingGrowthCompany
false
CY2023 dei Icfr Auditor Attestation Flag
IcfrAuditorAttestationFlag
true
CY2023 dei Document Accounting Standard
DocumentAccountingStandard
U.S. GAAP
CY2023 dei Entity Shell Company
EntityShellCompany
false
CY2023 dei Auditor Firm
AuditorFirmId
1424
CY2023 dei Auditor Name
AuditorName
PricewaterhouseCoopers Zhong Tian LLP
CY2023Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
2472959000
CY2023 dei Auditor Location
AuditorLocation
Shanghai, the People’s Republic of China
CY2022Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
9751824000
CY2023Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
348309000
CY2022Q4 bz Time Deposits Current
TimeDepositsCurrent
793042000
CY2023Q4 bz Time Deposits Current
TimeDepositsCurrent
6922803000
CY2023Q4 bz Time Deposits Current
TimeDepositsCurrent
975056000
CY2022Q4 us-gaap Short Term Investments
ShortTermInvestments
2665047000
CY2023Q4 us-gaap Short Term Investments
ShortTermInvestments
3513885000
CY2023Q4 us-gaap Short Term Investments
ShortTermInvestments
494920000
CY2022Q4 us-gaap Accounts Receivable Net Current
AccountsReceivableNetCurrent
9862000
CY2023Q4 us-gaap Accounts Receivable Net Current
AccountsReceivableNetCurrent
16727000
CY2023Q4 us-gaap Accounts Receivable Net Current
AccountsReceivableNetCurrent
2356000
CY2022Q4 us-gaap Prepaid Expense And Other Assets Current
PrepaidExpenseAndOtherAssetsCurrent
600773000
CY2023Q4 us-gaap Prepaid Expense And Other Assets Current
PrepaidExpenseAndOtherAssetsCurrent
442697000
CY2023Q4 us-gaap Prepaid Expense And Other Assets Current
PrepaidExpenseAndOtherAssetsCurrent
62353000
CY2022Q4 us-gaap Assets Current
AssetsCurrent
13826262000
CY2023Q4 us-gaap Assets Current
AssetsCurrent
13373037000
CY2023Q4 us-gaap Assets Current
AssetsCurrent
1883553000
CY2022Q4 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
691036000
CY2023Q4 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
1793488000
CY2023Q4 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
252607000
CY2022Q4 us-gaap Intangible Assets Net Excluding Goodwill
IntangibleAssetsNetExcludingGoodwill
10251000
CY2023Q4 us-gaap Intangible Assets Net Excluding Goodwill
IntangibleAssetsNetExcludingGoodwill
8093000
CY2023Q4 us-gaap Intangible Assets Net Excluding Goodwill
IntangibleAssetsNetExcludingGoodwill
1140000
CY2022Q4 us-gaap Goodwill
Goodwill
5690000
CY2023Q4 us-gaap Goodwill
Goodwill
5690000
CY2023Q4 us-gaap Goodwill
Goodwill
801000
CY2022Q4 us-gaap Operating Lease Right Of Use Asset
OperatingLeaseRightOfUseAsset
289628000
CY2023Q4 us-gaap Operating Lease Right Of Use Asset
OperatingLeaseRightOfUseAsset
282612000
CY2023Q4 us-gaap Operating Lease Right Of Use Asset
OperatingLeaseRightOfUseAsset
39805000
CY2023Q4 us-gaap Long Term Investments
LongTermInvestments
2473128000
CY2023Q4 us-gaap Long Term Investments
LongTermInvestments
348333000
CY2022Q4 us-gaap Other Assets Noncurrent
OtherAssetsNoncurrent
4000000
CY2023Q4 us-gaap Other Assets Noncurrent
OtherAssetsNoncurrent
4000000
CY2023Q4 us-gaap Other Assets Noncurrent
OtherAssetsNoncurrent
563000
CY2022Q4 us-gaap Assets Noncurrent
AssetsNoncurrent
1000605000
CY2023Q4 us-gaap Assets Noncurrent
AssetsNoncurrent
4567011000
CY2023Q4 us-gaap Assets Noncurrent
AssetsNoncurrent
643249000
CY2022Q4 us-gaap Assets
Assets
14826867000
CY2023Q4 us-gaap Assets
Assets
17940048000
CY2023Q4 us-gaap Assets
Assets
2526802000
CY2022Q4 us-gaap Accounts Payable Current
AccountsPayableCurrent
185297000
CY2023Q4 us-gaap Accounts Payable Current
AccountsPayableCurrent
629216000
CY2023Q4 us-gaap Accounts Payable Current
AccountsPayableCurrent
88623000
CY2022Q4 us-gaap Contract With Customer Liability Current
ContractWithCustomerLiabilityCurrent
2060892000
CY2023Q4 us-gaap Contract With Customer Liability Current
ContractWithCustomerLiabilityCurrent
2794075000
CY2023Q4 us-gaap Contract With Customer Liability Current
ContractWithCustomerLiabilityCurrent
393537000
CY2022Q4 us-gaap Accrued Liabilities And Other Liabilities
AccruedLiabilitiesAndOtherLiabilities
633482000
CY2023Q4 us-gaap Accrued Liabilities And Other Liabilities
AccruedLiabilitiesAndOtherLiabilities
779046000
CY2023Q4 us-gaap Accrued Liabilities And Other Liabilities
AccruedLiabilitiesAndOtherLiabilities
109726000
CY2022Q4 us-gaap Operating Lease Liability Current
OperatingLeaseLiabilityCurrent
151438000
CY2023Q4 us-gaap Operating Lease Liability Current
OperatingLeaseLiabilityCurrent
155014000
CY2023Q4 us-gaap Operating Lease Liability Current
OperatingLeaseLiabilityCurrent
21833000
CY2022Q4 us-gaap Liabilities Current
LiabilitiesCurrent
3031109000
CY2023Q4 us-gaap Liabilities Current
LiabilitiesCurrent
4357351000
CY2023Q4 us-gaap Liabilities Current
LiabilitiesCurrent
613719000
CY2022Q4 us-gaap Operating Lease Liability Noncurrent
OperatingLeaseLiabilityNoncurrent
143591000
CY2023Q4 us-gaap Operating Lease Liability Noncurrent
OperatingLeaseLiabilityNoncurrent
125079000
CY2023Q4 us-gaap Operating Lease Liability Noncurrent
OperatingLeaseLiabilityNoncurrent
17617000
CY2022Q4 us-gaap Deferred Income Tax Liabilities Net
DeferredIncomeTaxLiabilitiesNet
11404000
CY2023Q4 us-gaap Deferred Income Tax Liabilities Net
DeferredIncomeTaxLiabilitiesNet
28425000
CY2023Q4 us-gaap Deferred Income Tax Liabilities Net
DeferredIncomeTaxLiabilitiesNet
4004000
CY2022Q4 us-gaap Liabilities Noncurrent
LiabilitiesNoncurrent
154995000
CY2023Q4 us-gaap Liabilities Noncurrent
LiabilitiesNoncurrent
153504000
CY2023Q4 us-gaap Liabilities Noncurrent
LiabilitiesNoncurrent
21621000
CY2022Q4 us-gaap Liabilities
Liabilities
3186104000
CY2023Q4 us-gaap Liabilities
Liabilities
4510855000
CY2023Q4 us-gaap Liabilities
Liabilities
635340000
CY2022Q4 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.0001
CY2023Q4 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.0001
CY2022Q4 us-gaap Common Stock Value
CommonStockValue
564000
CY2023Q4 us-gaap Common Stock Value
CommonStockValue
564000
CY2023Q4 us-gaap Common Stock Value
CommonStockValue
79000
CY2022Q4 us-gaap Treasury Stock Common Value
TreasuryStockCommonValue
918894000
CY2023Q4 us-gaap Treasury Stock Common Value
TreasuryStockCommonValue
479730000
CY2023Q4 us-gaap Treasury Stock Common Value
TreasuryStockCommonValue
67569000
CY2022Q4 us-gaap Additional Paid In Capital
AdditionalPaidInCapital
15450389000
CY2023Q4 us-gaap Additional Paid In Capital
AdditionalPaidInCapital
15496811000
CY2023Q4 us-gaap Additional Paid In Capital
AdditionalPaidInCapital
2182680000
CY2023Q4 bz Statutory Reserves
StatutoryReserves
5000000
CY2023Q4 bz Statutory Reserves
StatutoryReserves
704000
CY2022Q4 us-gaap Accumulated Other Comprehensive Income Loss Net Of Tax
AccumulatedOtherComprehensiveIncomeLossNetOfTax
695184000
CY2023Q4 us-gaap Accumulated Other Comprehensive Income Loss Net Of Tax
AccumulatedOtherComprehensiveIncomeLossNetOfTax
898810000
CY2023Q4 us-gaap Accumulated Other Comprehensive Income Loss Net Of Tax
AccumulatedOtherComprehensiveIncomeLossNetOfTax
126595000
CY2022Q4 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-3586480000
CY2023Q4 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-2492253000
CY2023Q4 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-351026000
CY2022Q4 us-gaap Stockholders Equity
StockholdersEquity
11640763000
CY2023Q4 us-gaap Stockholders Equity
StockholdersEquity
13429202000
CY2023Q4 us-gaap Stockholders Equity
StockholdersEquity
1891463000
CY2023Q4 us-gaap Minority Interest
MinorityInterest
-9000
CY2023Q4 us-gaap Minority Interest
MinorityInterest
-1000
CY2022Q4 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
11640763000
CY2023Q4 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
13429193000
CY2023Q4 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
1891462000
CY2022Q4 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
14826867000
CY2023Q4 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
17940048000
CY2023Q4 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
2526802000
CY2021 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
4259128000
CY2022 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
4511062000
CY2023 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
5952028000
CY2023 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
838326000
CY2021 us-gaap Cost Of Goods And Services Sold
CostOfGoodsAndServicesSold
554648000
CY2022 us-gaap Cost Of Goods And Services Sold
CostOfGoodsAndServicesSold
754861000
CY2023 us-gaap Cost Of Goods And Services Sold
CostOfGoodsAndServicesSold
1059861000
CY2023 us-gaap Cost Of Goods And Services Sold
CostOfGoodsAndServicesSold
149278000
CY2021 us-gaap Selling And Marketing Expense
SellingAndMarketingExpense
1942670000
CY2022 us-gaap Selling And Marketing Expense
SellingAndMarketingExpense
2000900000
CY2023 us-gaap Selling And Marketing Expense
SellingAndMarketingExpense
1991226000
CY2023 us-gaap Selling And Marketing Expense
SellingAndMarketingExpense
280458000
CY2021 us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
821984000
CY2022 us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
1182716000
CY2023 us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
1543568000
CY2023 us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
217407000
CY2021 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
1991123000
CY2022 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
719699000
CY2023 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
811787000
CY2023 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
114338000
CY2021 us-gaap Costs And Expenses
CostsAndExpenses
5310425000
CY2022 us-gaap Costs And Expenses
CostsAndExpenses
4658176000
CY2023 us-gaap Costs And Expenses
CostsAndExpenses
5406442000
CY2023 us-gaap Costs And Expenses
CostsAndExpenses
761481000
CY2021 us-gaap Other Operating Income Expense Net
OtherOperatingIncomeExpenseNet
14977000
CY2022 us-gaap Other Operating Income Expense Net
OtherOperatingIncomeExpenseNet
17595000
CY2023 us-gaap Other Operating Income Expense Net
OtherOperatingIncomeExpenseNet
35385000
CY2023 us-gaap Other Operating Income Expense Net
OtherOperatingIncomeExpenseNet
4984000
CY2021 us-gaap Operating Income Loss
OperatingIncomeLoss
-1036320000
CY2022 us-gaap Operating Income Loss
OperatingIncomeLoss
-129519000
CY2023 us-gaap Operating Income Loss
OperatingIncomeLoss
580971000
CY2023 us-gaap Operating Income Loss
OperatingIncomeLoss
81829000
CY2021 bz Interest And Investment Income
InterestAndInvestmentIncome
34479000
CY2022 bz Interest And Investment Income
InterestAndInvestmentIncome
226482000
CY2023 bz Interest And Investment Income
InterestAndInvestmentIncome
606757000
CY2023 bz Interest And Investment Income
InterestAndInvestmentIncome
85460000
CY2021 us-gaap Foreign Currency Transaction Gain Loss Before Tax
ForeignCurrencyTransactionGainLossBeforeTax
-1961000
CY2022 us-gaap Foreign Currency Transaction Gain Loss Before Tax
ForeignCurrencyTransactionGainLossBeforeTax
8627000
CY2023 us-gaap Foreign Currency Transaction Gain Loss Before Tax
ForeignCurrencyTransactionGainLossBeforeTax
1088000
CY2023 us-gaap Foreign Currency Transaction Gain Loss Before Tax
ForeignCurrencyTransactionGainLossBeforeTax
153000
CY2021 us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
-7745000
CY2022 us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
11406000
CY2023 us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
32973000
CY2023 us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
4644000
CY2021 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
-1011547000
CY2022 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
116996000
CY2023 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
1221789000
CY2023 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
172086000
CY2021 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
59527000
CY2022 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
9751000
CY2023 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
122571000
CY2023 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
17264000
CY2021 us-gaap Profit Loss
ProfitLoss
-1071074000
CY2022 us-gaap Profit Loss
ProfitLoss
107245000
CY2023 us-gaap Profit Loss
ProfitLoss
1099218000
CY2023 us-gaap Profit Loss
ProfitLoss
154822000
CY2021 us-gaap Temporary Equity Accretion To Redemption Value Adjustment
TemporaryEquityAccretionToRedemptionValueAdjustment
164065000
CY2023 us-gaap Net Income Loss Attributable To Noncontrolling Interest
NetIncomeLossAttributableToNoncontrollingInterest
-9000
CY2023 us-gaap Net Income Loss Attributable To Noncontrolling Interest
NetIncomeLossAttributableToNoncontrollingInterest
-1000
CY2021 us-gaap Net Income Loss Available To Common Stockholders Basic
NetIncomeLossAvailableToCommonStockholdersBasic
-1235139000
CY2022 us-gaap Net Income Loss Available To Common Stockholders Basic
NetIncomeLossAvailableToCommonStockholdersBasic
107245000
CY2023 us-gaap Net Income Loss Available To Common Stockholders Basic
NetIncomeLossAvailableToCommonStockholdersBasic
1099227000
CY2023 us-gaap Net Income Loss Available To Common Stockholders Basic
NetIncomeLossAvailableToCommonStockholdersBasic
154823000
CY2021 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
529343027
CY2022 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
868941151
CY2023 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
870304878
CY2023 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
870304878
CY2021 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
529343027
CY2022 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
912141991
CY2023 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
902735995
CY2023 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
902735995
CY2021 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-2.33
CY2022 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
0.12
CY2023 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
1.26
CY2023 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
0.18
CY2021 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-2.33
CY2022 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
0.12
CY2023 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
1.22
CY2023 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
0.17
CY2021 us-gaap Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax
OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax
-127378000
CY2022 us-gaap Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax
OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax
952949000
CY2023 us-gaap Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax
OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax
186976000
CY2023 us-gaap Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax
OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax
26335000
CY2023 us-gaap Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Net Of Tax
OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax
16650000
CY2023 us-gaap Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Net Of Tax
OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax
2345000
CY2021 us-gaap Other Comprehensive Income Loss Net Of Tax
OtherComprehensiveIncomeLossNetOfTax
-127378000
CY2022 us-gaap Other Comprehensive Income Loss Net Of Tax
OtherComprehensiveIncomeLossNetOfTax
952949000
CY2023 us-gaap Other Comprehensive Income Loss Net Of Tax
OtherComprehensiveIncomeLossNetOfTax
203626000
CY2023 us-gaap Other Comprehensive Income Loss Net Of Tax
OtherComprehensiveIncomeLossNetOfTax
28680000
CY2021 us-gaap Comprehensive Income Net Of Tax Including Portion Attributable To Noncontrolling Interest
ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest
-1198452000
CY2022 us-gaap Comprehensive Income Net Of Tax Including Portion Attributable To Noncontrolling Interest
ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest
1060194000
CY2023 us-gaap Comprehensive Income Net Of Tax Including Portion Attributable To Noncontrolling Interest
ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest
1302844000
CY2023 us-gaap Comprehensive Income Net Of Tax Including Portion Attributable To Noncontrolling Interest
ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest
183502000
CY2021 us-gaap Temporary Equity Accretion To Redemption Value Adjustment
TemporaryEquityAccretionToRedemptionValueAdjustment
164065000
CY2023 us-gaap Comprehensive Income Net Of Tax Attributable To Noncontrolling Interest
ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest
-9000
CY2023 us-gaap Comprehensive Income Net Of Tax Attributable To Noncontrolling Interest
ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest
-1000
CY2021 us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
-1362517000
CY2022 us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
1060194000
CY2023 us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
1302853000
CY2023 us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
183503000
CY2020Q4 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
-2300117000
CY2021 us-gaap Profit Loss
ProfitLoss
-1071074000
CY2021 us-gaap Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax
OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax
-127378000
CY2021 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
417284000
CY2021 us-gaap Adjustments To Additional Paid In Capital Increase In Carrying Amount Of Redeemable Preferred Stock
AdjustmentsToAdditionalPaidInCapitalIncreaseInCarryingAmountOfRedeemablePreferredStock
164065000
CY2021 us-gaap Stock Repurchased And Retired During Period Value
StockRepurchasedAndRetiredDuringPeriodValue
-42264000
CY2021 us-gaap Stock Issued During Period Value Conversion Of Convertible Securities
StockIssuedDuringPeriodValueConversionOfConvertibleSecurities
5854661000
CY2021 bz Stock Issued During Period Value Stock Options Exercised And Restricted Stock Units Vested
StockIssuedDuringPeriodValueStockOptionsExercisedAndRestrictedStockUnitsVested
193775000
CY2021Q4 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
10674056000
CY2022 us-gaap Profit Loss
ProfitLoss
107245000
CY2022 us-gaap Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax
OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax
952949000
CY2022 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
692204000
CY2022 bz Stock Issued During Period Value Stock Options Exercised And Restricted Stock Units Vested
StockIssuedDuringPeriodValueStockOptionsExercisedAndRestrictedStockUnitsVested
133809000
CY2022 us-gaap Treasury Stock Value Acquired Cost Method
TreasuryStockValueAcquiredCostMethod
918894000
CY2022Q4 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
11640763000
CY2023 us-gaap Profit Loss
ProfitLoss
1099218000
CY2023 us-gaap Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax
OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax
186976000
CY2023 us-gaap Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Net Of Tax
OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax
16650000
CY2023 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
1056967000
CY2023 bz Stock Issued During Period Value Stock Options Exercised And Restricted Stock Units Vested
StockIssuedDuringPeriodValueStockOptionsExercisedAndRestrictedStockUnitsVested
181568000
CY2023 us-gaap Treasury Stock Value Acquired Cost Method
TreasuryStockValueAcquiredCostMethod
184698000
CY2023 us-gaap Dividends Common Stock Cash
DividendsCommonStockCash
568251000
CY2023Q4 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
13429193000
CY2021 us-gaap Profit Loss
ProfitLoss
-1071074000
CY2022 us-gaap Profit Loss
ProfitLoss
107245000
CY2023 us-gaap Profit Loss
ProfitLoss
1099218000
CY2023 us-gaap Profit Loss
ProfitLoss
154822000
CY2021 us-gaap Share Based Compensation
ShareBasedCompensation
417284000
CY2022 us-gaap Share Based Compensation
ShareBasedCompensation
692204000
CY2023 us-gaap Share Based Compensation
ShareBasedCompensation
1056967000
CY2023 us-gaap Share Based Compensation
ShareBasedCompensation
148871000
CY2021 bz Share Based Compensation Others
ShareBasedCompensationOthers
1506362000
CY2021 us-gaap Depreciation And Amortization
DepreciationAndAmortization
80100000
CY2022 us-gaap Depreciation And Amortization
DepreciationAndAmortization
140078000
CY2023 us-gaap Depreciation And Amortization
DepreciationAndAmortization
258752000
CY2023 us-gaap Depreciation And Amortization
DepreciationAndAmortization
36444000
CY2021 us-gaap Gain Loss On Sale Of Property Plant Equipment
GainLossOnSaleOfPropertyPlantEquipment
-110000
CY2022 us-gaap Gain Loss On Sale Of Property Plant Equipment
GainLossOnSaleOfPropertyPlantEquipment
96000
CY2023 us-gaap Gain Loss On Sale Of Property Plant Equipment
GainLossOnSaleOfPropertyPlantEquipment
-183000
CY2023 us-gaap Gain Loss On Sale Of Property Plant Equipment
GainLossOnSaleOfPropertyPlantEquipment
-26000
CY2021 us-gaap Foreign Currency Transaction Gain Loss Before Tax
ForeignCurrencyTransactionGainLossBeforeTax
-1961000
CY2022 us-gaap Foreign Currency Transaction Gain Loss Before Tax
ForeignCurrencyTransactionGainLossBeforeTax
8627000
CY2023 us-gaap Foreign Currency Transaction Gain Loss Before Tax
ForeignCurrencyTransactionGainLossBeforeTax
1088000
CY2023 us-gaap Foreign Currency Transaction Gain Loss Before Tax
ForeignCurrencyTransactionGainLossBeforeTax
153000
CY2021 us-gaap Operating Lease Right Of Use Asset Amortization Expense
OperatingLeaseRightOfUseAssetAmortizationExpense
109336000
CY2022 us-gaap Operating Lease Right Of Use Asset Amortization Expense
OperatingLeaseRightOfUseAssetAmortizationExpense
147322000
CY2023 us-gaap Operating Lease Right Of Use Asset Amortization Expense
OperatingLeaseRightOfUseAssetAmortizationExpense
169137000
CY2023 us-gaap Operating Lease Right Of Use Asset Amortization Expense
OperatingLeaseRightOfUseAssetAmortizationExpense
23822000
CY2021 us-gaap Unrealized Gain Loss On Investments
UnrealizedGainLossOnInvestments
6595000
CY2022 us-gaap Unrealized Gain Loss On Investments
UnrealizedGainLossOnInvestments
43716000
CY2023 us-gaap Unrealized Gain Loss On Investments
UnrealizedGainLossOnInvestments
288042000
CY2023 us-gaap Unrealized Gain Loss On Investments
UnrealizedGainLossOnInvestments
40570000
CY2022 us-gaap Deferred Income Tax Expense Benefit
DeferredIncomeTaxExpenseBenefit
9324000
CY2023 us-gaap Deferred Income Tax Expense Benefit
DeferredIncomeTaxExpenseBenefit
14083000
CY2023 us-gaap Deferred Income Tax Expense Benefit
DeferredIncomeTaxExpenseBenefit
1984000
CY2022 bz Allowance For Doubtful Accounts
AllowanceForDoubtfulAccounts
336000
CY2023 bz Allowance For Doubtful Accounts
AllowanceForDoubtfulAccounts
86000
CY2023 bz Allowance For Doubtful Accounts
AllowanceForDoubtfulAccounts
12000
CY2021 us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
-5997000
CY2022 us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
5982000
CY2023 us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
7037000
CY2023 us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
991000
CY2021 us-gaap Increase Decrease In Prepaid Deferred Expense And Other Assets
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
403696000
CY2022 us-gaap Increase Decrease In Prepaid Deferred Expense And Other Assets
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
-13321000
CY2023 us-gaap Increase Decrease In Prepaid Deferred Expense And Other Assets
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
-123933000
CY2023 us-gaap Increase Decrease In Prepaid Deferred Expense And Other Assets
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
-17456000
CY2021 us-gaap Increase Decrease In Due From Related Parties
IncreaseDecreaseInDueFromRelatedParties
-3503000
CY2022 us-gaap Increase Decrease In Due From Related Parties
IncreaseDecreaseInDueFromRelatedParties
-901000
CY2023 us-gaap Increase Decrease In Due From Related Parties
IncreaseDecreaseInDueFromRelatedParties
-1748000
CY2023 us-gaap Increase Decrease In Due From Related Parties
IncreaseDecreaseInDueFromRelatedParties
-246000
CY2021 us-gaap Increase Decrease In Other Noncurrent Assets
IncreaseDecreaseInOtherNoncurrentAssets
4000000
CY2021 us-gaap Increase Decrease In Accounts Payable
IncreaseDecreaseInAccountsPayable
13464000
CY2022 us-gaap Increase Decrease In Accounts Payable
IncreaseDecreaseInAccountsPayable
10179000
CY2023 us-gaap Increase Decrease In Accounts Payable
IncreaseDecreaseInAccountsPayable
24744000
CY2023 us-gaap Increase Decrease In Accounts Payable
IncreaseDecreaseInAccountsPayable
3485000
CY2021 us-gaap Increase Decrease In Contract With Customer Liability
IncreaseDecreaseInContractWithCustomerLiability
758221000
CY2022 us-gaap Increase Decrease In Contract With Customer Liability
IncreaseDecreaseInContractWithCustomerLiability
102322000
CY2023 us-gaap Increase Decrease In Contract With Customer Liability
IncreaseDecreaseInContractWithCustomerLiability
733183000
CY2023 us-gaap Increase Decrease In Contract With Customer Liability
IncreaseDecreaseInContractWithCustomerLiability
103266000
CY2021 us-gaap Increase Decrease In Other Accounts Payable And Accrued Liabilities
IncreaseDecreaseInOtherAccountsPayableAndAccruedLiabilities
329802000
CY2022 us-gaap Increase Decrease In Other Accounts Payable And Accrued Liabilities
IncreaseDecreaseInOtherAccountsPayableAndAccruedLiabilities
-18037000
CY2023 us-gaap Increase Decrease In Other Accounts Payable And Accrued Liabilities
IncreaseDecreaseInOtherAccountsPayableAndAccruedLiabilities
31931000
CY2023 us-gaap Increase Decrease In Other Accounts Payable And Accrued Liabilities
IncreaseDecreaseInOtherAccountsPayableAndAccruedLiabilities
4497000
CY2021 us-gaap Increase Decrease In Operating Lease Liability
IncreaseDecreaseInOperatingLeaseLiability
-99394000
CY2022 us-gaap Increase Decrease In Operating Lease Liability
IncreaseDecreaseInOperatingLeaseLiability
-143732000
CY2023 us-gaap Increase Decrease In Operating Lease Liability
IncreaseDecreaseInOperatingLeaseLiability
-170789000
CY2023 us-gaap Increase Decrease In Operating Lease Liability
IncreaseDecreaseInOperatingLeaseLiability
-24055000
CY2021 us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
1641381000
CY2022 us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
1003042000
CY2023 us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
3047009000
CY2023 us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
429162000
CY2021 us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
259891000
CY2022 us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
340120000
CY2023 us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
955511000
CY2023 us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
134581000
CY2021 us-gaap Proceeds From Sale Of Property Plant And Equipment
ProceedsFromSaleOfPropertyPlantAndEquipment
29000
CY2022 us-gaap Proceeds From Sale Of Property Plant And Equipment
ProceedsFromSaleOfPropertyPlantAndEquipment
324000
CY2023 us-gaap Proceeds From Sale Of Property Plant And Equipment
ProceedsFromSaleOfPropertyPlantAndEquipment
6953000
CY2023 us-gaap Proceeds From Sale Of Property Plant And Equipment
ProceedsFromSaleOfPropertyPlantAndEquipment
979000
CY2021 bz Payments To Acquire Time Deposits And Short Term Investments
PaymentsToAcquireTimeDepositsAndShortTermInvestments
3940000000
CY2022 bz Payments To Acquire Time Deposits And Short Term Investments
PaymentsToAcquireTimeDepositsAndShortTermInvestments
5213058000
CY2023 bz Payments To Acquire Time Deposits And Short Term Investments
PaymentsToAcquireTimeDepositsAndShortTermInvestments
16867453000
CY2023 bz Payments To Acquire Time Deposits And Short Term Investments
PaymentsToAcquireTimeDepositsAndShortTermInvestments
2375732000
CY2021 bz Proceeds From Maturities And Calls Of Time Deposits And Short Term Investments
ProceedsFromMaturitiesAndCallsOfTimeDepositsAndShortTermInvestments
3598000000
CY2022 bz Proceeds From Maturities And Calls Of Time Deposits And Short Term Investments
ProceedsFromMaturitiesAndCallsOfTimeDepositsAndShortTermInvestments
2746201000
CY2023 bz Proceeds From Maturities And Calls Of Time Deposits And Short Term Investments
ProceedsFromMaturitiesAndCallsOfTimeDepositsAndShortTermInvestments
10272111000
CY2023 bz Proceeds From Maturities And Calls Of Time Deposits And Short Term Investments
ProceedsFromMaturitiesAndCallsOfTimeDepositsAndShortTermInvestments
1446797000
CY2023 us-gaap Payments To Acquire Longterm Investments
PaymentsToAcquireLongtermInvestments
2394679000
CY2023 us-gaap Payments To Acquire Longterm Investments
PaymentsToAcquireLongtermInvestments
337283000
CY2022 us-gaap Payments To Acquire Businesses Net Of Cash Acquired
PaymentsToAcquireBusinessesNetOfCashAcquired
9928000
CY2023 us-gaap Payments To Acquire Businesses Net Of Cash Acquired
PaymentsToAcquireBusinessesNetOfCashAcquired
66000
CY2023 us-gaap Payments To Acquire Businesses Net Of Cash Acquired
PaymentsToAcquireBusinessesNetOfCashAcquired
9000
CY2021 us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-601862000
CY2022 us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-2816581000
CY2023 us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-9938645000
CY2023 us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-1399829000
CY2021 us-gaap Proceeds From Issuance Initial Public Offering
ProceedsFromIssuanceInitialPublicOffering
6406872000
CY2021 us-gaap Proceeds From Stock Options Exercised
ProceedsFromStockOptionsExercised
35975000
CY2022 us-gaap Proceeds From Stock Options Exercised
ProceedsFromStockOptionsExercised
249662000
CY2023 us-gaap Proceeds From Stock Options Exercised
ProceedsFromStockOptionsExercised
217712000
CY2023 us-gaap Proceeds From Stock Options Exercised
ProceedsFromStockOptionsExercised
30665000
CY2022 us-gaap Payments For Repurchase Of Common Stock
PaymentsForRepurchaseOfCommonStock
918894000
CY2023 us-gaap Payments For Repurchase Of Common Stock
PaymentsForRepurchaseOfCommonStock
71835000
CY2023 us-gaap Payments For Repurchase Of Common Stock
PaymentsForRepurchaseOfCommonStock
10118000
CY2023 us-gaap Payments Of Dividends
PaymentsOfDividends
562899000
CY2023 us-gaap Payments Of Dividends
PaymentsOfDividends
79283000
CY2021 us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
6431263000
CY2022 us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
-669232000
CY2023 us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
-417022000
CY2023 us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
-58736000
CY2021 us-gaap Effect Of Exchange Rate On Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
-127227000
CY2022 us-gaap Effect Of Exchange Rate On Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
892837000
CY2023 us-gaap Effect Of Exchange Rate On Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
29793000
CY2023 us-gaap Effect Of Exchange Rate On Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
4196000
CY2021 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
7343555000
CY2022 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
-1589934000
CY2023 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
-7278865000
CY2023 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
-1025207000
CY2020Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
3998203000
CY2021Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
11341758000
CY2022Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
9751824000
CY2022Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
1373516000
CY2021Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
11341758000
CY2022Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
9751824000
CY2023Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
2472959000
CY2023Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
348309000
CY2022 us-gaap Income Taxes Paid Net
IncomeTaxesPaidNet
101293000
CY2023 us-gaap Income Taxes Paid Net
IncomeTaxesPaidNet
133456000
CY2023 us-gaap Income Taxes Paid Net
IncomeTaxesPaidNet
18797000
CY2021 us-gaap Temporary Equity Accretion To Redemption Value Adjustment
TemporaryEquityAccretionToRedemptionValueAdjustment
164065000
CY2021 bz Increase Decrease In Payables For Purchase Of Property Equipment And Software
IncreaseDecreaseInPayablesForPurchaseOfPropertyEquipmentAndSoftware
-2357000
CY2022 bz Increase Decrease In Payables For Purchase Of Property Equipment And Software
IncreaseDecreaseInPayablesForPurchaseOfPropertyEquipmentAndSoftware
122155000
CY2023 bz Increase Decrease In Payables For Purchase Of Property Equipment And Software
IncreaseDecreaseInPayablesForPurchaseOfPropertyEquipmentAndSoftware
419175000
CY2023 bz Increase Decrease In Payables For Purchase Of Property Equipment And Software
IncreaseDecreaseInPayablesForPurchaseOfPropertyEquipmentAndSoftware
59040000
CY2023 bz Share Repurchase Consideration Not Yet Paid
ShareRepurchaseConsiderationNotYetPaid
113802000
CY2023 bz Share Repurchase Consideration Not Yet Paid
ShareRepurchaseConsiderationNotYetPaid
16029000
CY2023 us-gaap Use Of Estimates
UseOfEstimates
<p style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-weight:bold;text-align:justify;margin:0pt 0pt 12pt 0pt;"><span style="display:inline-block;text-align:left;text-indent:0pt;width:18pt;"><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:italic;font-weight:bold;">(c)</span></span><span style="font-style:italic;">Use of estimates</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;text-indent:0pt;margin:0pt 0pt 12pt 18pt;">The preparation of the consolidated financial statements in conformity with U.S. GAAP requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities at the balance sheet dates and revenues and expenses during the reporting periods. Accounting estimates reflected in the Group’s consolidated financial statements include, but are not limited to, useful lives of property, equipment and software and intangible assets, impairment assessments of long-lived assets and goodwill, fair value of assets acquired and liabilities assumed in a business combination and available-for-sale debt security investments, valuation allowance for deferred tax assets, the provision for credit losses of financial assets and valuation of share-based compensation. Management bases the estimates on historical experience, known trends and various other assumptions that are believed to be reasonable under current circumstances. Actual results could differ from those estimates.</p>
CY2023Q4 bz Foreign Currency Translation Rate
ForeignCurrencyTranslationRate
7.0999
CY2021 us-gaap Advertising Expense
AdvertisingExpense
997700000
CY2022 us-gaap Advertising Expense
AdvertisingExpense
793200000
CY2023 us-gaap Advertising Expense
AdvertisingExpense
582100000
CY2021 us-gaap Defined Contribution Plan Cost Recognized
DefinedContributionPlanCostRecognized
256500000
CY2022 us-gaap Defined Contribution Plan Cost Recognized
DefinedContributionPlanCostRecognized
395200000
CY2023 us-gaap Defined Contribution Plan Cost Recognized
DefinedContributionPlanCostRecognized
449800000
CY2021 us-gaap Number Of Reportable Segments
NumberOfReportableSegments
1
CY2022 us-gaap Number Of Reportable Segments
NumberOfReportableSegments
1
CY2023 us-gaap Number Of Reportable Segments
NumberOfReportableSegments
1
CY2022Q4 us-gaap Short Term Investments
ShortTermInvestments
2665047000
CY2023Q4 us-gaap Short Term Investments
ShortTermInvestments
3513885000
CY2023Q4 us-gaap Long Term Investments
LongTermInvestments
2473128000
CY2022Q4 bz Receivables From Thirdparty On Line Payment Platforms
ReceivablesFromThirdpartyOnLinePaymentPlatforms
30317000
CY2023Q4 bz Receivables From Thirdparty On Line Payment Platforms
ReceivablesFromThirdpartyOnLinePaymentPlatforms
96560000
CY2022Q4 bz Prepaid Advertising Expenses And Service Fee
PrepaidAdvertisingExpensesAndServiceFee
211604000
CY2023Q4 bz Prepaid Advertising Expenses And Service Fee
PrepaidAdvertisingExpensesAndServiceFee
95318000
CY2022Q4 bz Receivables Related To The Exercise Of Share Based Awards
ReceivablesRelatedToTheExerciseOfShareBasedAwards
172452000
CY2023Q4 bz Receivables Related To The Exercise Of Share Based Awards
ReceivablesRelatedToTheExerciseOfShareBasedAwards
79182000
CY2022Q4 us-gaap Deposit Assets
DepositAssets
68390000
CY2023Q4 us-gaap Deposit Assets
DepositAssets
63201000
CY2022Q4 us-gaap Prepaid Taxes
PrepaidTaxes
42380000
CY2023Q4 us-gaap Prepaid Taxes
PrepaidTaxes
46277000
CY2022Q4 bz Staff Loans And Advances
StaffLoansAndAdvances
33672000
CY2023Q4 bz Staff Loans And Advances
StaffLoansAndAdvances
25744000
CY2022Q4 us-gaap Other Assets Current
OtherAssetsCurrent
41958000
CY2023Q4 us-gaap Other Assets Current
OtherAssetsCurrent
36415000
CY2022Q4 us-gaap Prepaid Expense And Other Assets Current
PrepaidExpenseAndOtherAssetsCurrent
600773000
CY2023Q4 us-gaap Prepaid Expense And Other Assets Current
PrepaidExpenseAndOtherAssetsCurrent
442697000
CY2022Q4 us-gaap Property Plant And Equipment Gross
PropertyPlantAndEquipmentGross
972415000
CY2023Q4 us-gaap Property Plant And Equipment Gross
PropertyPlantAndEquipmentGross
2323747000
CY2022Q4 us-gaap Accumulated Depreciation Depletion And Amortization Property Plant And Equipment
AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
281379000
CY2023Q4 us-gaap Accumulated Depreciation Depletion And Amortization Property Plant And Equipment
AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
530259000
CY2022Q4 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
691036000
CY2023Q4 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
1793488000
CY2021 us-gaap Depreciation
Depreciation
80000000.0
CY2022 us-gaap Depreciation
Depreciation
139500000
CY2023 us-gaap Depreciation
Depreciation
256600000
CY2022Q4 us-gaap Taxes Payable Current
TaxesPayableCurrent
152598000
CY2023Q4 us-gaap Taxes Payable Current
TaxesPayableCurrent
116657000
CY2023Q4 bz Consideration Payable For Share Repurchase
ConsiderationPayableForShareRepurchase
113387000
CY2022Q4 bz Advance From Customers Current
AdvanceFromCustomersCurrent
58630000
CY2022Q4 bz Payables For Purchase Of Property Equipment And Software
PayablesForPurchaseOfPropertyEquipmentAndSoftware
142142000
CY2023Q4 bz Payables For Purchase Of Property Equipment And Software
PayablesForPurchaseOfPropertyEquipmentAndSoftware
561317000
CY2022Q4 us-gaap Accrued Marketing Costs Current
AccruedMarketingCostsCurrent
32277000
CY2023Q4 us-gaap Accrued Marketing Costs Current
AccruedMarketingCostsCurrent
15369000
CY2022Q4 us-gaap Accounts Payable Other Current
AccountsPayableOtherCurrent
10878000
CY2023Q4 us-gaap Accounts Payable Other Current
AccountsPayableOtherCurrent
52530000
CY2022Q4 us-gaap Accounts Payable Current
AccountsPayableCurrent
185297000
CY2023Q4 us-gaap Accounts Payable Current
AccountsPayableCurrent
629216000
CY2022Q4 us-gaap Employee Related Liabilities Current
EmployeeRelatedLiabilitiesCurrent
366454000
CY2023Q4 us-gaap Employee Related Liabilities Current
EmployeeRelatedLiabilitiesCurrent
457974000
CY2023Q4 bz Advance From Customers Current
AdvanceFromCustomersCurrent
73196000
CY2022Q4 us-gaap Other Accrued Liabilities Current
OtherAccruedLiabilitiesCurrent
55800000
CY2023Q4 us-gaap Other Accrued Liabilities Current
OtherAccruedLiabilitiesCurrent
17832000
CY2022Q4 us-gaap Accrued Liabilities And Other Liabilities
AccruedLiabilitiesAndOtherLiabilities
633482000
CY2023Q4 us-gaap Accrued Liabilities And Other Liabilities
AccruedLiabilitiesAndOtherLiabilities
779046000
CY2021 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
4259128000
CY2022 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
4511062000
CY2023 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
5952028000
CY2021 us-gaap Operating Lease Expense
OperatingLeaseExpense
116091000
CY2022 us-gaap Operating Lease Expense
OperatingLeaseExpense
162448000
CY2023 us-gaap Operating Lease Expense
OperatingLeaseExpense
182591000
CY2021 us-gaap Short Term Lease Cost
ShortTermLeaseCost
2177000
CY2022 us-gaap Short Term Lease Cost
ShortTermLeaseCost
1947000
CY2023 us-gaap Short Term Lease Cost
ShortTermLeaseCost
4424000
CY2021 us-gaap Operating Lease Cost
OperatingLeaseCost
118268000
CY2022 us-gaap Operating Lease Cost
OperatingLeaseCost
164395000
CY2023 us-gaap Operating Lease Cost
OperatingLeaseCost
187015000
CY2022Q4 us-gaap Operating Lease Right Of Use Asset
OperatingLeaseRightOfUseAsset
289628000
CY2023Q4 us-gaap Operating Lease Right Of Use Asset
OperatingLeaseRightOfUseAsset
282612000
CY2022Q4 us-gaap Operating Lease Liability Current
OperatingLeaseLiabilityCurrent
151438000
CY2023Q4 us-gaap Operating Lease Liability Current
OperatingLeaseLiabilityCurrent
155014000
CY2022Q4 us-gaap Operating Lease Liability Noncurrent
OperatingLeaseLiabilityNoncurrent
143591000
CY2023Q4 us-gaap Operating Lease Liability Noncurrent
OperatingLeaseLiabilityNoncurrent
125079000
CY2022Q4 us-gaap Operating Lease Liability
OperatingLeaseLiability
295029000
CY2023Q4 us-gaap Operating Lease Liability
OperatingLeaseLiability
280093000
CY2022Q4 us-gaap Operating Lease Weighted Average Remaining Lease Term1
OperatingLeaseWeightedAverageRemainingLeaseTerm1
P2Y7M6D
CY2023Q4 us-gaap Operating Lease Weighted Average Remaining Lease Term1
OperatingLeaseWeightedAverageRemainingLeaseTerm1
P2Y18D
CY2022Q4 us-gaap Operating Lease Weighted Average Discount Rate Percent
OperatingLeaseWeightedAverageDiscountRatePercent
0.0481
CY2023Q4 us-gaap Operating Lease Weighted Average Discount Rate Percent
OperatingLeaseWeightedAverageDiscountRatePercent
0.0477
CY2021 us-gaap Operating Lease Payments
OperatingLeasePayments
102154000
CY2022 us-gaap Operating Lease Payments
OperatingLeasePayments
154626000
CY2023 us-gaap Operating Lease Payments
OperatingLeasePayments
184101000
CY2021 us-gaap Right Of Use Asset Obtained In Exchange For Operating Lease Liability
RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability
274358000
CY2022 us-gaap Right Of Use Asset Obtained In Exchange For Operating Lease Liability
RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability
139968000
CY2023 us-gaap Right Of Use Asset Obtained In Exchange For Operating Lease Liability
RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability
248325000
CY2023Q4 us-gaap Lessee Operating Lease Liability Payments Due Next Twelve Months
LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths
158723000
CY2023Q4 us-gaap Lessee Operating Lease Liability Payments Due Year Two
LesseeOperatingLeaseLiabilityPaymentsDueYearTwo
113895000
CY2023Q4 us-gaap Lessee Operating Lease Liability Payments Due Year Three
LesseeOperatingLeaseLiabilityPaymentsDueYearThree
20894000
CY2023Q4 us-gaap Lessee Operating Lease Liability Payments Due Year Four
LesseeOperatingLeaseLiabilityPaymentsDueYearFour
455000
CY2023Q4 bz Lessee Operating Lease Liability Payments Due After Year Four
LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFour
0
CY2023Q4 us-gaap Lessee Operating Lease Liability Payments Due
LesseeOperatingLeaseLiabilityPaymentsDue
293967000
CY2023Q4 us-gaap Lessee Operating Lease Liability Undiscounted Excess Amount
LesseeOperatingLeaseLiabilityUndiscountedExcessAmount
13874000
CY2023Q4 us-gaap Operating Lease Liability
OperatingLeaseLiability
280093000
CY2020Q4 us-gaap Deferred Tax Assets Valuation Allowance
DeferredTaxAssetsValuationAllowance
250032000
CY2021Q4 us-gaap Deferred Tax Assets Valuation Allowance
DeferredTaxAssetsValuationAllowance
334848000
CY2021 us-gaap Income Loss From Continuing Operations Before Income Taxes Domestic
IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic
610813000
CY2022 us-gaap Income Loss From Continuing Operations Before Income Taxes Domestic
IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic
125529000
CY2023 us-gaap Income Loss From Continuing Operations Before Income Taxes Domestic
IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic
809506000
CY2021 us-gaap Income Loss From Continuing Operations Before Income Taxes Foreign
IncomeLossFromContinuingOperationsBeforeIncomeTaxesForeign
-1622360000
CY2022 us-gaap Income Loss From Continuing Operations Before Income Taxes Foreign
IncomeLossFromContinuingOperationsBeforeIncomeTaxesForeign
-8533000
CY2023 us-gaap Income Loss From Continuing Operations Before Income Taxes Foreign
IncomeLossFromContinuingOperationsBeforeIncomeTaxesForeign
412283000
CY2021 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
-1011547000
CY2022 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
116996000
CY2023 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
1221789000
CY2021 us-gaap Current Income Tax Expense Benefit
CurrentIncomeTaxExpenseBenefit
59527000
CY2022 us-gaap Current Income Tax Expense Benefit
CurrentIncomeTaxExpenseBenefit
427000
CY2023 us-gaap Current Income Tax Expense Benefit
CurrentIncomeTaxExpenseBenefit
108488000
CY2022 us-gaap Deferred Income Tax Expense Benefit
DeferredIncomeTaxExpenseBenefit
9324000
CY2023 us-gaap Deferred Income Tax Expense Benefit
DeferredIncomeTaxExpenseBenefit
14083000
CY2021 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
59527000
CY2022 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
9751000
CY2023 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
122571000
CY2023 us-gaap Effective Income Tax Rate Reconciliation At Federal Statutory Income Tax Rate
EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate
0.25
CY2021 us-gaap Effective Income Tax Rate Reconciliation At Federal Statutory Income Tax Rate
EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate
0.2500
CY2022 us-gaap Effective Income Tax Rate Reconciliation At Federal Statutory Income Tax Rate
EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate
0.2500
CY2023 us-gaap Effective Income Tax Rate Reconciliation At Federal Statutory Income Tax Rate
EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate
0.2500
CY2021 us-gaap Effective Income Tax Rate Reconciliation Foreign Income Tax Rate Differential
EffectiveIncomeTaxRateReconciliationForeignIncomeTaxRateDifferential
-0.3789
CY2022 us-gaap Effective Income Tax Rate Reconciliation Foreign Income Tax Rate Differential
EffectiveIncomeTaxRateReconciliationForeignIncomeTaxRateDifferential
-0.2195
CY2023 us-gaap Effective Income Tax Rate Reconciliation Foreign Income Tax Rate Differential
EffectiveIncomeTaxRateReconciliationForeignIncomeTaxRateDifferential
-0.0572
CY2021 bz Effective Income Tax Rate Reconciliation Effect Of Preferential Tax Rates
EffectiveIncomeTaxRateReconciliationEffectOfPreferentialTaxRates
0.0515
CY2022 bz Effective Income Tax Rate Reconciliation Effect Of Preferential Tax Rates
EffectiveIncomeTaxRateReconciliationEffectOfPreferentialTaxRates
-0.1043
CY2023 bz Effective Income Tax Rate Reconciliation Effect Of Preferential Tax Rates
EffectiveIncomeTaxRateReconciliationEffectOfPreferentialTaxRates
-0.0772
CY2021 bz Effective Income Tax Rate Reconciliation Permanent Difference
EffectiveIncomeTaxRateReconciliationPermanentDifference
0.0124
CY2022 bz Effective Income Tax Rate Reconciliation Permanent Difference
EffectiveIncomeTaxRateReconciliationPermanentDifference
-0.1100
CY2023 bz Effective Income Tax Rate Reconciliation Permanent Difference
EffectiveIncomeTaxRateReconciliationPermanentDifference
0.0036
CY2021 us-gaap Effective Income Tax Rate Reconciliation Change In Deferred Tax Assets Valuation Allowance
EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance
-0.0838
CY2022 us-gaap Effective Income Tax Rate Reconciliation Change In Deferred Tax Assets Valuation Allowance
EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance
0.1663
CY2023 us-gaap Effective Income Tax Rate Reconciliation Change In Deferred Tax Assets Valuation Allowance
EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance
-0.0240
CY2021 us-gaap Effective Income Tax Rate Reconciliation Other Adjustments
EffectiveIncomeTaxRateReconciliationOtherAdjustments
0.0900
CY2022 us-gaap Effective Income Tax Rate Reconciliation Other Adjustments
EffectiveIncomeTaxRateReconciliationOtherAdjustments
0.1008
CY2023 us-gaap Effective Income Tax Rate Reconciliation Other Adjustments
EffectiveIncomeTaxRateReconciliationOtherAdjustments
0.0051
CY2021 us-gaap Effective Income Tax Rate Continuing Operations
EffectiveIncomeTaxRateContinuingOperations
-0.0588
CY2022 us-gaap Effective Income Tax Rate Continuing Operations
EffectiveIncomeTaxRateContinuingOperations
0.0833
CY2023 us-gaap Effective Income Tax Rate Continuing Operations
EffectiveIncomeTaxRateContinuingOperations
0.1003
CY2022Q4 bz Deferred Tax Assets Deductible Advertising Expenses
DeferredTaxAssetsDeductibleAdvertisingExpenses
272810000
CY2023Q4 bz Deferred Tax Assets Deductible Advertising Expenses
DeferredTaxAssetsDeductibleAdvertisingExpenses
225344000
CY2022Q4 us-gaap Deferred Tax Assets Operating Loss Carryforwards
DeferredTaxAssetsOperatingLossCarryforwards
94704000
CY2023Q4 us-gaap Deferred Tax Assets Operating Loss Carryforwards
DeferredTaxAssetsOperatingLossCarryforwards
99606000
CY2022Q4 us-gaap Deferred Tax Assets Other
DeferredTaxAssetsOther
58000
CY2023Q4 us-gaap Deferred Tax Assets Other
DeferredTaxAssetsOther
77000
CY2022Q4 us-gaap Deferred Tax Assets Gross
DeferredTaxAssetsGross
367572000
CY2023Q4 us-gaap Deferred Tax Assets Gross
DeferredTaxAssetsGross
325027000
CY2022Q4 us-gaap Deferred Tax Assets Valuation Allowance
DeferredTaxAssetsValuationAllowance
354306000
CY2023Q4 us-gaap Deferred Tax Assets Valuation Allowance
DeferredTaxAssetsValuationAllowance
325027000
CY2022Q4 us-gaap Deferred Tax Assets Net
DeferredTaxAssetsNet
13266000
CY2022Q4 bz Deferred Tax Liabilities Accelerated Tax Depreciation
DeferredTaxLiabilitiesAcceleratedTaxDepreciation
22693000
CY2023Q4 bz Deferred Tax Liabilities Accelerated Tax Depreciation
DeferredTaxLiabilitiesAcceleratedTaxDepreciation
19122000
CY2023Q4 bz Deferred Tax Liabilities Unrealized Gains On Investment
DeferredTaxLiabilitiesUnrealizedGainsOnInvestment
7740000
CY2022Q4 us-gaap Deferred Tax Liabilities Goodwill And Intangible Assets Intangible Assets
DeferredTaxLiabilitiesGoodwillAndIntangibleAssetsIntangibleAssets
1977000
CY2023Q4 us-gaap Deferred Tax Liabilities Goodwill And Intangible Assets Intangible Assets
DeferredTaxLiabilitiesGoodwillAndIntangibleAssetsIntangibleAssets
1563000
CY2022Q4 us-gaap Deferred Income Tax Liabilities
DeferredIncomeTaxLiabilities
24670000
CY2023Q4 us-gaap Deferred Income Tax Liabilities
DeferredIncomeTaxLiabilities
28425000
CY2022Q4 us-gaap Deferred Income Tax Liabilities Net
DeferredIncomeTaxLiabilitiesNet
11404000
CY2023Q4 us-gaap Deferred Income Tax Liabilities Net
DeferredIncomeTaxLiabilitiesNet
28425000
CY2023Q4 us-gaap Operating Loss Carryforwards
OperatingLossCarryforwards
401600000
CY2022Q4 us-gaap Deferred Tax Assets Valuation Allowance
DeferredTaxAssetsValuationAllowance
354306000
CY2021 us-gaap Valuation Allowance Deferred Tax Asset Change In Amount
ValuationAllowanceDeferredTaxAssetChangeInAmount
84816000
CY2022 us-gaap Valuation Allowance Deferred Tax Asset Change In Amount
ValuationAllowanceDeferredTaxAssetChangeInAmount
19458000
CY2023 us-gaap Valuation Allowance Deferred Tax Asset Change In Amount
ValuationAllowanceDeferredTaxAssetChangeInAmount
-29279000
CY2021Q4 us-gaap Deferred Tax Assets Valuation Allowance
DeferredTaxAssetsValuationAllowance
334848000
CY2022Q4 us-gaap Deferred Tax Assets Valuation Allowance
DeferredTaxAssetsValuationAllowance
354306000
CY2023Q4 us-gaap Deferred Tax Assets Valuation Allowance
DeferredTaxAssetsValuationAllowance
325027000
CY2023Q4 us-gaap Dividends Common Stock Cash
DividendsCommonStockCash
79200000
CY2021 us-gaap Dividends
Dividends
0
CY2022 us-gaap Dividends
Dividends
0
CY2020Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
107133353
CY2020Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice
1.16
CY2020 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Outstanding Weighted Average Remaining Contractual Term2
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2
P6Y10M2D
CY2020Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Intrinsic Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue
226639
CY2020Q4 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Nonvested Weighted Average Grant Date Fair Value
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedWeightedAverageGrantDateFairValue
0.64
CY2021 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Gross
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross
32710153
CY2021 us-gaap Share Based Compensation Arrangements By Share Based Payment Award Options Grants In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice
4.14
CY2021 us-gaap Stock Issued During Period Shares Stock Options Exercised
StockIssuedDuringPeriodSharesStockOptionsExercised
54385484
CY2021 us-gaap Share Based Compensation Arrangements By Share Based Payment Award Options Exercises In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice
0.55
CY2021 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Forfeitures In Period
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod
2982054
CY2021 us-gaap Share Based Compensation Arrangements By Share Based Payment Award Options Forfeitures In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice
1.98
CY2021Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
82475968
CY2021Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice
2.71
CY2021 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Outstanding Weighted Average Remaining Contractual Term2
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2
P8Y18D
CY2021Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Intrinsic Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue
1214916
CY2021Q4 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Nonvested Weighted Average Grant Date Fair Value
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedWeightedAverageGrantDateFairValue
2.82
CY2022 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Gross
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross
8424
CY2022 us-gaap Share Based Compensation Arrangements By Share Based Payment Award Options Grants In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice
0.00
CY2022 us-gaap Stock Issued During Period Shares Stock Options Exercised
StockIssuedDuringPeriodSharesStockOptionsExercised
12413256
CY2022 us-gaap Share Based Compensation Arrangements By Share Based Payment Award Options Exercises In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice
1.59
CY2022 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Forfeitures In Period
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod
1709938
CY2022 us-gaap Share Based Compensation Arrangements By Share Based Payment Award Options Forfeitures In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice
3.39
CY2022Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
68361198
CY2022Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice
2.90
CY2022 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Outstanding Weighted Average Remaining Contractual Term2
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2
P7Y2M23D
CY2022Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Intrinsic Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue
498336
CY2022Q4 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Nonvested Weighted Average Grant Date Fair Value
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedWeightedAverageGrantDateFairValue
2.99
CY2023 us-gaap Stock Issued During Period Shares Stock Options Exercised
StockIssuedDuringPeriodSharesStockOptionsExercised
11810406
CY2023 us-gaap Share Based Compensation Arrangements By Share Based Payment Award Options Exercises In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice
2.16
CY2023 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Forfeitures In Period
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod
718812
CY2023 us-gaap Share Based Compensation Arrangements By Share Based Payment Award Options Forfeitures In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice
4.09
CY2023Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
55831980
CY2023Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice
3.04
CY2023 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Outstanding Weighted Average Remaining Contractual Term2
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2
P6Y4M2D
CY2023Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Intrinsic Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue
294189
CY2023Q4 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Nonvested Weighted Average Grant Date Fair Value
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedWeightedAverageGrantDateFairValue
3.15
CY2023Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Vested And Expected To Vest Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingNumber
55831980
CY2023Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Vested And Expected To Vest Outstanding Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageExercisePrice
3.04
CY2023 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Vested And Expected To Vest Outstanding Weighted Average Remaining Contractual Term1
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageRemainingContractualTerm1
P6Y4M2D
CY2023Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Vested And Expected To Vest Outstanding Aggregate Intrinsic Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingAggregateIntrinsicValue
294189
CY2023Q4 bz Share Based Compensation Arrangement By Share Based Payment Award Options Vested And Expected To Vest Weighted Average Grant Date Fair Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestWeightedAverageGrantDateFairValue
3.15
CY2023Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber
37075572
CY2023Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice
2.54
CY2023 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Exercisable Weighted Average Remaining Contractual Term1
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1
P5Y11M8D
CY2023Q4 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Exercisable Intrinsic Value1
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1
213744
CY2023Q4 bz Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Weighted Average Grant Date Fair Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageGrantDateFairValue
2.24
CY2022 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Weighted Average Grant Date Fair Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue
12.13
CY2021 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Fair Value Assumptions Expected Term1
SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1
P10Y
CY2021 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Dividend Rate
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate
0
CY2021 us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
1923646000
CY2022 us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
692204000
CY2023 us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
1056967000
CY2021 us-gaap Net Income Loss Available To Common Stockholders Basic
NetIncomeLossAvailableToCommonStockholdersBasic
-1235139000
CY2022 us-gaap Net Income Loss Available To Common Stockholders Basic
NetIncomeLossAvailableToCommonStockholdersBasic
107245000
CY2023 us-gaap Net Income Loss Available To Common Stockholders Basic
NetIncomeLossAvailableToCommonStockholdersBasic
1099227000
CY2021 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
529343027
CY2022 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
868941151
CY2023 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
870304878
CY2022 us-gaap Incremental Common Shares Attributable To Share Based Payment Arrangements
IncrementalCommonSharesAttributableToShareBasedPaymentArrangements
43200840
CY2023 us-gaap Incremental Common Shares Attributable To Share Based Payment Arrangements
IncrementalCommonSharesAttributableToShareBasedPaymentArrangements
32431117
CY2021 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
529343027
CY2022 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
912141991
CY2023 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
902735995
CY2021 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-2.33
CY2022 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
0.12
CY2023 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
1.26
CY2021 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-2.33
CY2022 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
0.12
CY2023 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
1.22
CY2021 us-gaap Asset Impairment Charges
AssetImpairmentCharges
0
CY2022 us-gaap Asset Impairment Charges
AssetImpairmentCharges
0
CY2023 us-gaap Asset Impairment Charges
AssetImpairmentCharges
0
CY2022Q4 us-gaap Gain Loss Related To Litigation Settlement
GainLossRelatedToLitigationSettlement
-2250000
CY2023Q4 us-gaap Amount Of Restricted Net Assets For Consolidated And Unconsolidated Subsidiaries
AmountOfRestrictedNetAssetsForConsolidatedAndUnconsolidatedSubsidiaries
943800000
CY2023Q4 bz Percentage Of Total Restricted Net Assets To Total Consolidated Net Assets
PercentageOfTotalRestrictedNetAssetsToTotalConsolidatedNetAssets
0.070

Files In Submission

Name View Source Status
0001104659-24-053379-index-headers.html Edgar Link pending
0001104659-24-053379-index.html Edgar Link pending
0001104659-24-053379.txt Edgar Link pending
0001104659-24-053379-xbrl.zip Edgar Link pending
bz-20231231.xsd Edgar Link pending
bz-20231231x20f.htm Edgar Link pending
bz-20231231x20f011.jpg Edgar Link pending
bz-20231231xex12d1.htm Edgar Link pending
bz-20231231xex12d2.htm Edgar Link pending
bz-20231231xex13d1.htm Edgar Link pending
bz-20231231xex13d2.htm Edgar Link pending
bz-20231231xex15d1.htm Edgar Link pending
bz-20231231xex15d2.htm Edgar Link pending
bz-20231231xex15d2001.jpg Edgar Link pending
bz-20231231xex15d3.htm Edgar Link pending
bz-20231231xex15d3001.jpg Edgar Link pending
bz-20231231xex4d5.htm Edgar Link pending
bz-20231231xex4d6.htm Edgar Link pending
bz-20231231xex4d7.htm Edgar Link pending
bz-20231231xex4d8.htm Edgar Link pending
bz-20231231xex4d9.htm Edgar Link pending
bz-20231231xex8d1.htm Edgar Link pending
bz-20231231xex97.htm Edgar Link pending
Financial_Report.xlsx Edgar Link pending
MetaLinks.json Edgar Link pending
R1.htm Edgar Link pending
R10.htm Edgar Link pending
R11.htm Edgar Link pending
R12.htm Edgar Link pending
R13.htm Edgar Link pending
R14.htm Edgar Link pending
R15.htm Edgar Link pending
R16.htm Edgar Link pending
R17.htm Edgar Link pending
R18.htm Edgar Link pending
R19.htm Edgar Link pending
R2.htm Edgar Link pending
R20.htm Edgar Link pending
R21.htm Edgar Link pending
bz-20231231_def.xml Edgar Link unprocessable
bz-20231231_lab.xml Edgar Link unprocessable
bz-20231231_pre.xml Edgar Link unprocessable
FilingSummary.xml Edgar Link unprocessable
bz-20231231x20f_htm.xml Edgar Link completed
R22.htm Edgar Link pending
R23.htm Edgar Link pending
R24.htm Edgar Link pending
R25.htm Edgar Link pending
R26.htm Edgar Link pending
R27.htm Edgar Link pending
R28.htm Edgar Link pending
R29.htm Edgar Link pending
R3.htm Edgar Link pending
R30.htm Edgar Link pending
R31.htm Edgar Link pending
R32.htm Edgar Link pending
R33.htm Edgar Link pending
R34.htm Edgar Link pending
R35.htm Edgar Link pending
R36.htm Edgar Link pending
R37.htm Edgar Link pending
R38.htm Edgar Link pending
R39.htm Edgar Link pending
R4.htm Edgar Link pending
R40.htm Edgar Link pending
R41.htm Edgar Link pending
R42.htm Edgar Link pending
R43.htm Edgar Link pending
R44.htm Edgar Link pending
R45.htm Edgar Link pending
R46.htm Edgar Link pending
R47.htm Edgar Link pending
R48.htm Edgar Link pending
R49.htm Edgar Link pending
R5.htm Edgar Link pending
R50.htm Edgar Link pending
R51.htm Edgar Link pending
R52.htm Edgar Link pending
R53.htm Edgar Link pending
R54.htm Edgar Link pending
R55.htm Edgar Link pending
R56.htm Edgar Link pending
R57.htm Edgar Link pending
R58.htm Edgar Link pending
R59.htm Edgar Link pending
R6.htm Edgar Link pending
R60.htm Edgar Link pending
R61.htm Edgar Link pending
R62.htm Edgar Link pending
R63.htm Edgar Link pending
R64.htm Edgar Link pending
R65.htm Edgar Link pending
R66.htm Edgar Link pending
R67.htm Edgar Link pending
R68.htm Edgar Link pending
R69.htm Edgar Link pending
R7.htm Edgar Link pending
R70.htm Edgar Link pending
R71.htm Edgar Link pending
R72.htm Edgar Link pending
R73.htm Edgar Link pending
R74.htm Edgar Link pending
R75.htm Edgar Link pending
R76.htm Edgar Link pending
R77.htm Edgar Link pending
R78.htm Edgar Link pending
R79.htm Edgar Link pending
R8.htm Edgar Link pending
R80.htm Edgar Link pending
R81.htm Edgar Link pending
R82.htm Edgar Link pending
R83.htm Edgar Link pending
R84.htm Edgar Link pending
R85.htm Edgar Link pending
R86.htm Edgar Link pending
R87.htm Edgar Link pending
R88.htm Edgar Link pending
R9.htm Edgar Link pending
report.css Edgar Link pending
Show.js Edgar Link pending
bz-20231231_cal.xml Edgar Link unprocessable